前列腺动脉栓塞术用于控制晚期前列腺癌患者的血尿
Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer.
作者信息
Chen Jhih-Wei, Shin Ji Hoon, Tsao Teng-Fu, Ko Heung-Gyu, Yoon Hyun-Ki, Han Ki-Chang, Thamtorawat Somrach, Hong Bumsik
机构信息
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea; Department of Medical Imaging, Chung Shan Medical University Hospital and School of Medicine, Taichung, Taiwan.
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea.
出版信息
J Vasc Interv Radiol. 2017 Feb;28(2):295-301. doi: 10.1016/j.jvir.2016.10.010.
Nine patients with advanced prostate cancer (stage T4) underwent prostatic arterial embolization (PAE) for refractory prostatic hematuria. Angiograms showed prostatic neovascularity in all cases, and complete PAE was achieved in 8 cases (89% technical success rate). Gross hematuria ceased after PAE in 6 cases, translating to a 67% clinical success rate. There were no PAE-related complications. At 3-month follow-up, 2 cases showed recurrent hematuria, 4 patients had died from PAE-unrelated etiologies, and only 3 patients survived and were without gross hematuria. PAE could represent an alternative option for patients with advanced prostate cancer to control hematuria.
9例晚期前列腺癌（T4期）患者因难治性前列腺血尿接受了前列腺动脉栓塞术（PAE）。血管造影显示所有病例均有前列腺新生血管形成，8例（技术成功率89%）成功完成了PAE。6例患者术后肉眼血尿停止，临床成功率为67%。未发生与PAE相关的并发症。在3个月的随访中，2例出现复发性血尿，4例患者死于与PAE无关的病因，只有3例患者存活且无肉眼血尿。PAE可能是晚期前列腺癌患者控制血尿的一种替代选择。
Zotero 插件